NEETPGAI
FeaturesNEET PGFMGEINI-CETBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • NEET PG Preparation
  • FMGE Preparation
  • INI-CET Preparation
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Lymphomas — Non-Hodgkin
    Lymphomas — Non-Hodgkin
    medium
    microscope Pathology

    A 38-year-old Indian woman presents with a 2-month history of painless left inguinal lymphadenopathy and intermittent fever. Physical examination reveals a 4 cm firm, matted lymph node in the left groin and no hepatosplenomegaly. Laboratory investigations show hemoglobin 11.5 g/dL, WBC 7,200/μL, and platelets 180,000/μL. Excisional lymph node biopsy shows effacement of normal architecture with a nodular growth pattern. Histology reveals small lymphocytes and scattered large cells with clear cytoplasm and prominent nucleoli. Immunohistochemistry shows CD20+, CD10+, BCL2+, and BCL6+ large cells. What is the most likely diagnosis?

    A. Diffuse large B-cell lymphoma
    B. Primary mediastinal B-cell lymphoma
    C. Burkitt lymphoma
    Follicular lymphoma
    D.

    Explanation

    Diagnosis: Follicular Lymphoma (Grade I–II)

    Clinical Presentation

    The patient presents with:

    • Painless lymphadenopathy (inguinal node)
    • Systemic symptoms (fever)
    • No hepatosplenomegaly
    • Normal blood counts
    • Young to middle-aged woman
    Key Point
    Follicular lymphoma is the second most common B-cell lymphoma worldwide. It typically presents with nodal disease, often in advanced stage (stage III–IV), but with preserved performance status and normal cytopenias.
    Histopathology — The Diagnostic Hallmark

    Nodular growth pattern with:

    • Neoplastic germinal centers composed of:
      • Centrocytes (small cleaved cells with irregular nuclei)
      • Centroblasts (large cells with vesicular nuclei and prominent nucleoli)
    • Preserved mantle zone at periphery
    • Small lymphocytes in interfollicular areas
    High-YieldNEET PG
    The nodular pattern of follicular lymphoma is distinct from the diffuse infiltration seen in other lymphomas. The presence of both small centrocytes and larger centroblasts within germinal center-like structures is pathognomonic.
    Immunophenotype — B-Cell Germinal Center Signature
    Table
    FeatureFollicularDLBCLBurkittPrimary Mediastinal
    CD20PositivePositivePositivePositive
    CD10PositiveNegative (except GCB type)NegativeNegative
    BCL2PositiveNegative (usually)NegativeNegative
    BCL6PositivePositive (GCB type)NegativeNegative
    CD5NegativeNegativeNegativeNegative
    MYC translocationNegativeNegative (usually)t(8;14)Negative
    t(14;18)Present (85%)AbsentAbsentAbsent
    Mnemonic
    Follicular = CD10 + BCL2 + t(14;18) — "Follicular has Four features: germinal center origin (CD10+), anti-apoptosis (BCL2+), and the t(14;18) translocation."
    Molecular Hallmark

    t(14;18)(q32;q21) juxtaposes BCL2 (chromosome 18) to the immunoglobulin heavy chain (IGH) locus (chromosome 14), resulting in constitutive BCL2 expression and resistance to apoptosis. This translocation is present in ~85% of follicular lymphomas and is virtually absent in other lymphomas.

    Clinical Pearl
    The presence of BCL2+ large cells (centroblasts) in a nodular pattern with CD10+ and BCL6+ phenotype is virtually diagnostic of follicular lymphoma. The t(14;18) translocation can be detected by fluorescence in situ hybridization (FISH) or PCR.
    Grading

    Follicular lymphomas are graded by the number of centroblasts per high-power field (hpf):

    • Grade I: 0–5 centroblasts/hpf
    • Grade II: 6–15 centroblasts/hpf
    • Grade III: >15 centroblasts/hpf (subdivided into IIIA and IIIB)

    This case, with scattered large cells and preserved nodular architecture, suggests Grade I–II follicular lymphoma.

    Why This Is Follicular Lymphoma and Not Other Lymphomas

    Diffuse large B-cell lymphoma (DLBCL) would show:

    • Diffuse infiltration (not nodular)
    • Predominantly large cells (>50% of cellularity)
    • CD10+ only in germinal center B-cell (GCB) subtype; BCL2 usually negative
    • Often presents with B symptoms and rapid progression
    • Higher grade, more aggressive course

    Burkitt lymphoma would show:

    • Diffuse infiltration with monomorphous medium-sized blasts
    • Starry-sky pattern (macrophages with tingible bodies)
    • CD10+, but BCL2− (no t(14;18))
    • t(8;14) translocation (MYC rearrangement)
    • Extremely aggressive, presents with high tumor burden
    • Young patients, often with extranodal disease

    Primary mediastinal B-cell lymphoma would show:

    • Mediastinal mass (not peripheral lymph node)
    • Sclerotic fibrosis and compartmentalization
    • CD20+, but CD10−, BCL2−
    • Often presents with chest symptoms or superior vena cava syndrome
    • Young women typically affected
    High-YieldNEET PG
    The nodular pattern + CD10+ + BCL2+ + t(14;18) triad is diagnostic of follicular lymphoma and excludes all other options.
    Clinical Course & Prognosis
    • Indolent course with median overall survival of 8–10 years (without treatment)
    • Often presents in advanced stage (III–IV) but with good performance status
    • Risk of Richter transformation to DLBCL (~3–5% per year)
    • Incurable with conventional chemotherapy; watch-and-wait is often appropriate for asymptomatic patients
    • Newer agents (anti-CD20, PI3K inhibitors, BTK inhibitors) improve outcomes
    Clinical Pearl
    Follicular lymphoma is a "watch-and-wait" disease in asymptomatic patients. Treatment is indicated for symptomatic disease, cytopenias, or rapid progression.

    Loading illustration…Lymphomas — Non-Hodgkin diagram

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →